Quorum Health Corp (NYSE:QHC) has been assigned an average rating of “Sell” from the seven brokerages that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $4.00.

A number of brokerages recently weighed in on QHC. Royal Bank of Canada restated a “hold” rating and issued a $5.00 price objective on shares of Quorum Health in a report on Tuesday, October 3rd. Zacks Investment Research lowered shares of Quorum Health from a “buy” rating to a “hold” rating in a research note on Thursday, October 12th. Finally, ValuEngine upgraded shares of Quorum Health from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st.

In related news, SVP Shaheed Koury bought 10,000 shares of the firm’s stock in a transaction on Monday, November 13th. The stock was acquired at an average cost of $4.69 per share, for a total transaction of $46,900.00. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. 4.70% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in QHC. California Public Employees Retirement System raised its stake in Quorum Health by 21.9% during the 1st quarter. California Public Employees Retirement System now owns 111,349 shares of the company’s stock valued at $606,000 after buying an additional 20,000 shares during the last quarter. Vanguard Group Inc. raised its stake in Quorum Health by 10.3% during the 1st quarter. Vanguard Group Inc. now owns 1,568,666 shares of the company’s stock valued at $8,534,000 after buying an additional 145,904 shares during the last quarter. Geode Capital Management LLC raised its stake in Quorum Health by 2.6% during the 1st quarter. Geode Capital Management LLC now owns 213,177 shares of the company’s stock valued at $1,159,000 after buying an additional 5,373 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Quorum Health by 12.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,092,288 shares of the company’s stock valued at $5,942,000 after buying an additional 124,723 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new stake in shares of Quorum Health during the 1st quarter valued at $459,000. Institutional investors and hedge funds own 81.83% of the company’s stock.

Shares of Quorum Health (NYSE:QHC) traded up $0.05 during midday trading on Thursday, reaching $4.97. 293,971 shares of the company were exchanged, compared to its average volume of 318,383. Quorum Health has a 52 week low of $2.54 and a 52 week high of $9.46. The company has a quick ratio of 1.68, a current ratio of 1.84 and a debt-to-equity ratio of 9.39.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/quorum-health-corp-qhc-given-average-rating-of-sell-by-analysts/1764511.html.

About Quorum Health

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.